Side-by-side comparison of AI visibility scores, market position, and capabilities
Dublin world's largest industrial gas company (NYSE: LIN) at $33B 2024 sales; 25.9% ROC, 29.5% op margin, $9.4B operating cash flow, semiconductor electronics gases + clean hydrogen competing with Air Liquide.
Linde plc is a Dublin, Ireland-incorporated global industrial gas and engineering company — publicly traded on the New York Stock Exchange (NYSE: LIN) as an S&P 500 Materials component and the world's largest industrial gas company by revenue and market capitalization — producing, distributing, and marketing atmospheric gases (oxygen, nitrogen, argon), process gases (hydrogen, helium, carbon dioxide, acetylene), and specialty gases for semiconductor manufacturing, healthcare, food and beverage, steel production, chemical processing, and energy applications through approximately 65,000 employees in 100 countries. In fiscal year 2024, Linde reported $33 billion in revenue, 25.9% return on capital (ROC), 29.5% operating margin, 10% EPS growth, $9.4 billion in operating cash flow, and returned $7.1 billion to shareholders through dividends and share repurchases — demonstrating industry-leading profitability metrics that reflect Linde's combination of long-term supply contracts, pricing power in specialty applications, and operational efficiency. Linde was formed from the $90 billion merger of Linde AG (Germany) and Praxair (US) completed in 2018, creating a combined industrial gas leader that nearly matches the scale of the other two major global industrial gas companies (Air Liquide and Air Products) combined. CEO Sanjiv Lamba leads Linde's strategy of expanding clean hydrogen production for energy transition, electronics gases supply for semiconductor manufacturing capacity additions, and healthcare oxygen delivery in emerging markets.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.